Nigel Brooks
About
In The Last Decade
Nigel Brooks
36 papers receiving 594 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 387
- Oncology 141
- Pulmonary and Respiratory Medicine 132
- Cancer Research 66
- Pathology and Forensic Medicine 54
Countries citing papers authored by Nigel Brooks
This map shows the geographic impact of Nigel Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Brooks more than expected).
Fields of papers citing papers by Nigel Brooks
This network shows the impact of papers produced by Nigel Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Brooks. The network helps show where Nigel Brooks may publish in the future.
Co-authorship network of co-authors of Nigel Brooks
This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Brooks. A scholar is included among the top collaborators of Nigel Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Brooks. Nigel Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 10 | |
| 3 | 6 | |
| 4 | 48 | |
| 5 | 6 | |
| 6 | 16 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 88 | |
| 10 | 3 | |
| 11 | 115 | |
| 12 | 16 | |
| 13 | 2 | |
| 14 | 36 | |
| 15 | 26 | |
| 16 | 11 | |
| 17 | 30 | |
| 18 | The combination of the specific endothelin A receptor antagonist ZD4054 and submaximal bisphosphonate pamidronate prevents soft-tissue metastasis | 1 |
| 19 | The combination of a specific endothelin A receptor antagonist ZD4054 and submaximal bisphosphonate pamidronate prevents bone metastasis | 3 |
| 20 | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.